The pharmacological management of depression
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Depressive disorders are common, recurrent, and chronic, and require treatment A review of the symptom picture and current drug targets demonstrates the need for accurate assessment of depression severity, including suicidality. The initial focus of treatment is rapid resolution of symptoms during an acute phase, followed by continuation. Maintenance treatment is indicated if the risk of recurrence is high. The range of available medications is considerable and the benefit/risk ratio is acceptable. Depression is diagnosable across the life span and treatable at every age (although recent disagreement has arisen with regard to young patients). Comorbidity, both psychiatric and medical, need to be assessed, as does the possible presence of two subtypes of depression (psychotic and bipolar) often requiring different interventions. It is expected that the next generation of antidepressants would be associated with more specific disease and outcome biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“2 million adults) in a recent survey.(1) According to the World Health Organization’s Global Burden of Disease Report,(2) major depression was the fourth leading cause of disease burden worldwide in 1990.”
Background(1996) · Cited by 6,884
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Depression Following Myocardial Infarction: Impact on 6-Month Survival
Frasure-Smith, N. (1993) · JAMA · doi:10.1001/jama.1993.03510150053029 · Cited by 1,939
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Interpersonal Psychotherapy Of Depression
Klerman, G. L. (1984) · Medical Entomology and Zoology · Cited by 1,315
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Self-citationThe cellular neurobiology of depression
Manji, H. K., Drevets, W. C., & Charney, D. S. (2001) · Nature Medicine · doi:10.1038/87865 · Cited by 1,182 · cited 1×
“Most recently, attention has moved from intrasynaptic changes in neurotransmitter levels to changes in intracellular signaling pathways.(9) In an important review, Manji and colleagues(9) raise the possibility that depression may be associated with impairments in signaling pathways that are considered important for th…”
Background
Research works printed but not linked: 11
- Richelson E., 2002, Psychopharmacol Bull., 36, 133
- Beck A., 1979, Cognitive Therapy of Depression. New York, NY: Guilford Press;
- Goldsmith SK., 2002, Institute of Medicine, National Academy of Sciences: Reducing Suicide, a National Imperative. Washington, DC: The National Academies Press;
- Liu B., 1996, Can Med Assoc J., 155, 519
- Schulberg HC., 1999, J Clin Psychiatry., 60, S19
- Pollock BG., 1999, J Clin Psychiatry., 60, S4
- Nierenberg AA., 1990, J Clin Psychiatry., 51, 39
- Thase ME., 1995, Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press;, 1081
- Paykel ES., 1994, Refractory Depression: Current Strategies and Future Directions. New York, NY: Wiley;, 3
- Keller M., 2001, J Am Acad Child Adolesc Psychiatry., 40, 762, 10.1097/00004583-200107000-00010 · DOI · Paper page
- Geddes JR., 2002, Depressive Disorders in Adults: Clinical Evidence. London, UK: BMJ Publishing Group;
Cited by
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Sexual Dysfunction, Depression, and the Impact of Antidepressants
Kennedy, S. H., & Rizvi, S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819c76e9 · Cited by 338
Johnston, K. M., Powell, L. C., Anderson, I. M., Szabo, S., & Cline, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.045 · Cited by 321
Lekman, M., Laje, G., Charney, D., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Lipsky, R., Wisniewski, S. R., Manji, H., McMahon, F. J., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.026 · Cited by 284
Ricken, R., Ulrich, S., Schlattmann, P., & Adli, M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.04.003 · Cited by 224
Metadata
- Authors
- Kupfer, D. J.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Kupfer, David J.
- ORCID
- Kupfer, David J.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2005-09-30
- Volume
- 7
- Issue
- 3
- Pages
- 191-205
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC3181740
- OpenAlex
- W16698172
- Cited by
- 69
- References
- 124
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 11 · 2021: 6 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 1 · 2012: 4
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH30915)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, pharmacotherapy, antidepressants, depression severity assessment, suicidality, acute phase treatment, continuation treatment, maintenance therapy, recurrence risk, comorbidities, psychotic depression, bipolar depression, young patients, biomarkers, therapeutic target
- MeSH terms
- Adolescent, Antidepressive Agents, Brain, Child, Depression, Female, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pharmacological management of depression. https://app.cochat.ai/papers/10.31887/dcns.2005.7.3/dkupfer
- The paper
- Kupfer, D. J. (2005). The pharmacological management of depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2005.7.3/dkupfer
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.